Fastox Pharma develops solutions to enhance the botulinum toxin onset of action and, most importantly, its duration of action. Our lead candidate, FTP-501, has shown remarkable enhancement profile with a very good safety profile. We are now preparing for the next step, a clinical study in human.
Company Details
- Founded
- 2018
- Address
- Rue Du Petit-Chêne 12, Lausanne,vaud 1003,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- biotech, pharma, botulinum toxin, biotech research.
- HQ
- Lausanne, Vaud
Fastox Pharma Sa Questions
Fastox Pharma Sa's LinkedIn profile is https://ch.linkedin.com/company/fastox-pharma-sa
Fastox Pharma Sa's industry is
Biotechnology Research
Fastox Pharma Sa's top competitors are
Acorn Biolabs,
Nagi Bioscience,
Glycocalyx Therapeutics Ag,
Lunaphore (A Bio-Techne Brand),
Remora Biotech,
Cytune Pharma,
Cellula Therapeutics Sa,
Activen Sa,
Bimini Health Tech,
Ogd2 Pharma.
Fastox Pharma Sa's categories are Biotechnology Research
Fastox Pharma Sa's founding year is 2018
